Evidence map›Paper›PMID 39370525›Full record

ReviewGut pathogens2024

Overview of pathogenic Escherichia coli, with a focus on Shiga toxin-producing serotypes, global outbreaks (1982-2024) and food safety criteria.

Meshari Ahmed Alhadlaq, Othman I Aljurayyad, Ayidh Almansour, Saleh I Al-Akeel, Khaloud O Alzahrani, Shahad A Alsalman, Reham Yahya, Rashad R Al-Hindi, Mohammed Ageeli Hakami, Saleh D Alshahrani and 6 more

Abstract readReview
In one paragraph

Review in Gut pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. GutGut microbes · 2026
    Article
  2. Multidrug-ResistantFoods (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Whole-Genome Sequencing ofMicroorganisms · 2026
    Article
  6. Article
  7. Article
  8. The Role of Selected Bacteria in Breast Cancer Initiation and Development.International journal of molecular sciences · 2026
    Review
  9. Virulome Landscape of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Effect ofJournal of veterinary research · 2026
    Article
  14. Fluoroquinolone-Resistant Avian PathogenicPathogens (Basel, Switzerland) · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Visual Screening of Genetic Polymorphisms inSensors (Basel, Switzerland) · 2026
    Article
  19. Whole-Genome Sequence Analysis of Colistin-Resistant,Antibiotics (Basel, Switzerland) · 2026
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Meshari Ahmed Alhadlaq *Saudi Food and Drug Authority, Riyadh, Saudi Arabia. MAHadlaq@sfda.gov.sa.ORCID http://orcid.org/0000-0002-1768-0976
Othman I Aljurayyad *Saudi Food and Drug Authority, Riyadh, Saudi Arabia.
Ayidh AlmansourSaudi Food and Drug Authority, Riyadh, Saudi Arabia.
Saleh I Al-AkeelSaudi Food and Drug Authority, Riyadh, Saudi Arabia.
Khaloud O AlzahraniSaudi Food and Drug Authority, Riyadh, Saudi Arabia.
Shahad A AlsalmanSaudi Food and Drug Authority, Riyadh, Saudi Arabia.
Reham YahyaClinical Infection and Microbiology Basic Sciences Department, King Saudi Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Rashad R Al-HindiDepartment of Biological Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Mohammed Ageeli HakamiDepartment of Clinical Laboratory Sciences, Shaqra University, Shaqra, Saudi Arabia.
Saleh D AlshahraniDepartment of Public Health Department, Ministry of Interior, Riyadh, Saudi Arabia.
Naif A AlhumeedDeputyship for Research & Innovation, Riyadh, Saudi Arabia.
Abdulaziz M Al MoneeaSaudi Food and Drug Authority, Riyadh, Saudi Arabia.
Mazen S Al-SeghayerSaudi Food and Drug Authority, Riyadh, Saudi Arabia.
Abdulmohsen L AlHarbiSaudi Food and Drug Authority, Riyadh, Saudi Arabia.
Fahad M Al-ReshoodiSaudi Food and Drug Authority, Riyadh, Saudi Arabia.
Suliman AlajelSaudi Food and Drug Authority, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Classification of pathogenic E. coli has been focused either in mammalian host or infection site, which offers limited resolution. This review presents a comprehensive framework for classifying all E. coli branches within a single, unifying figure. This approach integrates established methods based on virulence factors, serotypes and clinical syndromes, offering a more nuanced and informative perspective on E. coli pathogenicity. The presence of the LEE island in pathogenic E. coli is a key genetic marker differentiating EHEC from STEC strains. The coexistence of stx and eae genes within the bacterial genome is a primary characteristic used to distinguish STEC from other pathogenic E. coli strains. The presence of the inv plasmid, Afa/Dr adhesins, CFA-CS-LT-ST and EAST1 are key distinguishing features for identifying pathogenic E. coli strains belonging to EIEC, DAEC, ETEC and EAEC pathotypes respectively. Food microbiological criteria differentiate pathogenic E. coli in food matrices. 'Zero-tolerance' applies to most ready-to-eat (RTE) foods due to high illness risk. Non-RTE foods' roles may allow limited E. coli presence, which expose consumers to potential risk; particularly from the concerning Shiga toxin-producing E. coli (STEC) strains, which can lead to life-threatening complications in humans, including haemolytic uremic syndrome (HUS) and even death in susceptible individuals. These findings suggest that decision-makers should consider incorporating the separate detection of STEC serotypes into food microbiological criteria, in addition to existing enumeration methods. Contamination of STEC is mainly linked to food consumption, therefore, outbreaks of E. coli STEC has been reviewed here and showed a link also to water as a potential contamination route. Since their discovery in 1982, over 39,787 STEC cases associated with 1,343 outbreaks have been documented. The majority of these outbreaks occurred in the Americas, followed by Europe, Asia and Africa. The most common serotypes identified among the outbreaks were O157, the 'Big Six' (O26, O45, O103, O111, O121, and O145), and other serotypes such as O55, O80, O101, O104, O116, O165, O174 and O183. This review provides valuable insights into the most prevalent serotypes implicated in STEC outbreaks and identifies gaps in microbiological criteria, particularly for E. coli non-O157 and non-Big Six serotypes.

Indexed as

Big SixEpidemiologyEscherichia coliFood poisoningO157OutbreaksSFDA and Microbiological CriteriaSTEC

Identifiers

PMID39370525
PMCPMC11457481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.